CN107056736A - A kind of preparation method of mycophenolate mofetil - Google Patents
A kind of preparation method of mycophenolate mofetil Download PDFInfo
- Publication number
- CN107056736A CN107056736A CN201710315619.5A CN201710315619A CN107056736A CN 107056736 A CN107056736 A CN 107056736A CN 201710315619 A CN201710315619 A CN 201710315619A CN 107056736 A CN107056736 A CN 107056736A
- Authority
- CN
- China
- Prior art keywords
- mycophenolate mofetil
- preparation
- reaction
- diad
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种吗替麦考酚酯的制备方法,即麦考酚酸与吗啉乙醇,在三苯基膦、偶氮二甲酸二异丙酯(DIAD)作用下,经光延反应(Mitsunobu反应)制备吗替麦考酚酯,该方法反应条件温和,工艺简便,收率高,适合工业化生产。The invention discloses a method for preparing mycophenolate mofetil, that is, mycophenolic acid and morpholine ethanol are reacted by Mitsunobu under the action of triphenylphosphine and diisopropyl azodicarboxylate (DIAD) ( Mitsunobu reaction) to prepare mycophenolate mofetil, the method has mild reaction conditions, simple process, high yield, and is suitable for industrial production.
Description
技术领域technical field
本发明属于药物化学领域,具体涉及一种吗替麦考酚酯的制备方法。The invention belongs to the field of medicinal chemistry, and in particular relates to a preparation method of mycophenolate mofetil.
背景技术Background technique
吗替麦考酚酯( mycophenolate mofetil,MPM)是由瑞士罗氏(Roche)公司研发的一种新型免疫抑制剂,于1995年首次在美国上市,商品名为骁悉,在体内脱酯化后形成具有免疫抑制活性的代谢产物麦考酚酸( mycophenolic acid,MPA)。Mycophenolate mofetil (MPM) is a new type of immunosuppressant developed by Roche, Switzerland. It was first launched in the United States in 1995. Its trade name is Xiaoxi, and it is formed after deesterification in the body. The metabolite mycophenolic acid (MPA) with immunosuppressive activity.
它主要用于肾脏、心脏移植后器官排斥的预防。其作用机制是选择性抑制与排斥反应有关的T淋巴细胞和B淋巴细胞,并且有抑制动脉平滑肌增生的作用,后者是目前其它免疫抑制剂所没有的。归纳它的作用机制有如下几个特异性:(1)选择性抑制淋巴细胞鸟嘌呤经典合成途径,对非淋巴细胞和器官无毒性作用;(2)直接抑制B淋巴细胞增殖;(3)高效降低粘附分子的活性,抑制血管平滑肌细胞增殖,可预防及治疗血管性排斥反应和减少慢性排斥反应的发生。It is mainly used for the prevention of organ rejection after kidney and heart transplantation. Its mechanism of action is to selectively inhibit T lymphocytes and B lymphocytes related to rejection, and has the effect of inhibiting the proliferation of arterial smooth muscle, which is not found in other immunosuppressants at present. Its mechanism of action has the following specificities: (1) selectively inhibits the classic synthesis pathway of guanine in lymphocytes, and has no toxic effect on non-lymphocytes and organs; (2) directly inhibits the proliferation of B lymphocytes; (3) is highly effective Reducing the activity of adhesion molecules and inhibiting the proliferation of vascular smooth muscle cells can prevent and treat vascular rejection and reduce the occurrence of chronic rejection.
吗替麦考酚酯结构式Mycophenolate Mofetil Structural Formula
目前文献报道吗替麦考酚酯的合成工艺主要有以下几种:At present, the synthesis process of mycophenolate mofetil reported in the literature mainly contains the following types:
专利WO02100855、US5247083等采用直接酯化法,即麦考酚酸在甲苯、二甲苯、丁醚等高沸点溶剂中与吗啉乙醇在回流状态下直接酯化生成粗品,然后经一系列后处理得成品,此法反应时间长(通常需60-120 h),产物颜色深,需要脱色处理。Patents WO02100855, US5247083, etc. adopt the direct esterification method, that is, mycophenolic acid is directly esterified with morpholine ethanol in high boiling point solvents such as toluene, xylene, and butyl ether under reflux to form a crude product, and then undergoes a series of post-treatments to obtain Finished products, this method takes a long time to react (usually 60-120 h), and the product is dark in color and needs to be decolorized.
直接酯化法制备吗替麦考酚酯Preparation of mycophenolate mofetil by direct esterification
专利WO2000034503、WO2006024582利用生物酶催化合成吗替麦考酚酯,缺点是反应时间较长、收率较低、有大量反应原料残留;专利US4753935采用间接酯化法,即用麦考酚酸与酰氯反应生成麦考酚酰氯后,再与吗啉乙醇缩合生成产品,此法缺点在于需要两步合成步骤,酰氯及产生的酸性气体会对设备产生腐蚀,“三废”难处理,反应生成的杂质较多。Patents WO2000034503 and WO2006024582 use biological enzymes to catalyze the synthesis of mycophenolate mofetil. The disadvantages are that the reaction time is long, the yield is low, and a large amount of reaction raw materials remain; After the reaction produces mycophenolic acid chloride, it is condensed with morpholine ethanol to produce the product. The disadvantage of this method is that it requires two steps of synthesis. The acid gas and the acid gas produced will corrode the equipment. The "three wastes" are difficult to deal with, and the impurities generated by the reaction are relatively many.
间接酯化法制备吗替麦考酚酯Preparation of mycophenolate mofetil by indirect esterification
光延反应(Mitsunobu反应)是由日本化学家光延旺洋(Mitsunobu, O)等人于1967年发现,该反应能将醇通过与三苯基磷和偶氮二羧酸二乙酯(DEAD)反应转化为多种化合物,如酯,胺等。此反应的特点是条件温和,产率高并带有构型翻转。Mitsunobu reaction (Mitsunobu reaction) was discovered by Japanese chemist Mitsunobu, O and others in 1967. This reaction can react alcohol with triphenylphosphine and diethyl azodicarboxylate (DEAD) Converted into a variety of compounds such as esters, amines, etc. This reaction is characterized by mild conditions, high yield and configuration inversion.
光延反应方程式Mitsunobu Reaction Equation
本发明针对现有技术中的缺陷,首次采用光延反应(Mitsunobu反应)来制备吗替麦考酚酯,该方法反应条件温和,不需要长时间加热回流,也避免酸性气体产生,对设备无腐蚀,工艺简便,收率高,适合工业化生产。In view of the defects in the prior art, the present invention adopts the Mitsunobu reaction (Mitsunobu reaction) to prepare mycophenolate mofetil for the first time. The method has mild reaction conditions, does not need long-term heating and reflux, and avoids acid gas generation, and has no corrosion to equipment , the process is simple, the yield is high, and it is suitable for industrial production.
发明内容Contents of the invention
为了进一步实现本发明,本发明采用的技术方案为:In order to further realize the present invention, the technical scheme adopted in the present invention is:
一种吗替麦考酚酯的制备方法:麦考酚酸与吗啉乙醇,在三苯基膦、偶氮二甲酸二异丙酯(DIAD)作用下,经光延反应(Mitsunobu反应)制备吗替麦考酚酯。包括以下步骤:A preparation method of mycophenolate mofetil: Mycophenolic acid and morpholine ethanol are prepared by Mitsunobu reaction under the action of triphenylphosphine and diisopropyl azodicarboxylate (DIAD) mycophenolate mofetil. Include the following steps:
(1)氮气保护下,将三苯基膦、吗啉乙醇溶于反应溶剂,控制反应体系温度下依次加入DIAD溶液、麦考酚酸溶液,搅拌至反应结束;(1) Under the protection of nitrogen, dissolve triphenylphosphine and morpholine ethanol in the reaction solvent, add DIAD solution and mycophenolic acid solution successively under controlling the temperature of the reaction system, and stir until the reaction ends;
(2)步骤(1)所得反应液经水洗,萃取,浓缩后得到粗品,加入醇类溶剂重结晶一次,即可得到吗替麦考酚酯。(2) The reaction solution obtained in step (1) is washed with water, extracted, and concentrated to obtain a crude product, which is recrystallized once by adding an alcohol solvent to obtain mycophenolate mofetil.
反应式如下所示:The reaction formula is as follows:
步骤(1)中所述反应溶剂为二氯甲烷、乙酸乙酯、四氢呋喃、2-甲基四氢呋喃、二氧六环、甲苯,优选为二氯甲烷、乙酸乙酯。The reaction solvent described in step (1) is dichloromethane, ethyl acetate, tetrahydrofuran, 2-methyltetrahydrofuran, dioxane, toluene, preferably dichloromethane and ethyl acetate.
步骤(1)中所述各物料的摩尔比为:吗啉乙醇:麦考酚酸:三苯基膦:偶氮二甲酸二异丙酯(DIAD)=1.0: (1.0~2.5):(1.0~3.0):(1.0 ~3.0),优选为1.0:1.05:1.25:1.40。The mol ratio of each material described in step (1) is: morpholine ethanol: mycophenolic acid: triphenylphosphine: diisopropyl azodicarboxylate (DIAD)=1.0: (1.0 ~ 2.5): (1.0 ~3.0):(1.0~3.0), preferably 1.0:1.05:1.25:1.40.
步骤(1)中,加入DIAD溶液、麦考酚酸溶液时控制反应体系温度为0℃到10℃。优选为5℃。In step (1), when adding the DIAD solution and the mycophenolic acid solution, the temperature of the reaction system is controlled from 0°C to 10°C. Preferably it is 5°C.
步骤(1)中,偶氮二甲酸二异丙酯(DIAD)可由其类似物偶氮二甲酸二乙酯(DEAD)、偶氮二甲酸二叔丁酯、偶氮二甲酸二苯酯替代,优选为偶氮二甲酸二异丙酯、偶氮二甲酸二乙酯。In step (1), diisopropyl azodicarboxylate (DIAD) can be replaced by its analogs diethyl azodicarboxylate (DEAD), di-tert-butyl azodicarboxylate, diphenyl azodicarboxylate, Preferred are diisopropyl azodicarboxylate and diethyl azodicarboxylate.
步骤(1)中,三苯基膦可由其类似物二苯基甲基膦、三丁基膦替代,优选为三苯基膦。In step (1), triphenylphosphine can be replaced by its analogs diphenylmethylphosphine and tributylphosphine, preferably triphenylphosphine.
步骤(2)中,重结晶用醇类溶剂为无水乙醇、95%乙醇、异丙醇、甲醇,优选为无水乙醇。In step (2), the alcohol solvent for recrystallization is absolute ethanol, 95% ethanol, isopropanol, methanol, preferably absolute ethanol.
步骤(2)中,重结晶时的析晶温度为0-20℃,优选为10℃。In step (2), the crystallization temperature during recrystallization is 0-20°C, preferably 10°C.
本发明的优点在于:The advantages of the present invention are:
本发明公开了一种制备吗替麦考酚酯的新方法,首次采用光延反应(Mitsunobu反应)来制备吗替麦考酚酯,该方法反应条件温和,不需要长时间加热回流,避免酸性气体产生,对设备无腐蚀,工艺简便,收率高,适合工业化生产。The invention discloses a new method for preparing mycophenolate mofetil. For the first time, the Mitsunobu reaction is used to prepare mycophenolate mofetil. The method has mild reaction conditions, does not need long-term heating and reflux, and avoids acid gas Produced, no corrosion to equipment, simple process, high yield, suitable for industrial production.
具体实施方式detailed description
以下通过实施例对本发明做进一步详细说明,但不应就此理解为本发明上述主题范围内仅限于以下实施例。在不脱离本发明上述技术前提下,根据本领域普通技术知识和惯用手段做出的相应替换或变更的修改,均包括在本发明的范围内。The present invention will be further described in detail through the following examples, but it should not be understood that the scope of the above subject of the present invention is limited to the following examples. On the premise of not departing from the above technical premise of the present invention, the corresponding replacements or alterations made according to the common technical knowledge and customary means in this field are included in the scope of the present invention.
实施例1Example 1
在氮气保护下,Ph3P(32.8g,125mmol,1.25eq)、吗啉乙醇(13.1g,100mmol,1.0eq)溶于200ml二氯甲烷后,冷却至0℃,控制温度不超过5℃,在20-30min 内加入DIAD(28.3g,140mmol,1.4eq)的二氯甲烷(40ml)溶液,加毕,黄色溶液继续搅拌10min。再于0~5℃下加入麦考酚酸(33.6g,105mmol,1.05eq)的二氯甲烷(50ml)溶液,加毕,于室温下搅拌4h。将反应液倒入200 ml水中,搅拌5min,分液,有机相用120ml的1N盐酸溶液萃取一次,盐酸溶液接着用50ml乙酸乙酯洗一次,用饱和碳酸氢钠溶液调pH至8,有较多白色混浊析出,依次用80ml二氯甲烷、30ml二氯甲烷萃取,合并有机相,无水硫酸钠干燥,过滤,浓缩,得淡紫色油状液体。Under the protection of nitrogen, Ph 3 P (32.8g, 125mmol, 1.25eq) and morpholine ethanol (13.1g, 100mmol, 1.0eq) were dissolved in 200ml of dichloromethane, cooled to 0°C, and the temperature was controlled not to exceed 5°C. A solution of DIAD (28.3g, 140mmol, 1.4eq) in dichloromethane (40ml) was added within 20-30min. After the addition was complete, the yellow solution continued to stir for 10min. Then add a solution of mycophenolic acid (33.6g, 105mmol, 1.05eq) in dichloromethane (50ml) at 0~5°C, after the addition is complete, stir at room temperature for 4h. The reaction solution was poured into 200 ml of water, stirred for 5 min, separated, the organic phase was extracted once with 120 ml of 1N hydrochloric acid solution, the hydrochloric acid solution was washed once with 50 ml of ethyl acetate, and the pH was adjusted to 8 with saturated sodium bicarbonate solution. A lot of white turbidity was precipitated, extracted with 80ml dichloromethane and 30ml dichloromethane successively, combined the organic phases, dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a lavender oily liquid.
往淡紫色油状液体中加入350ml无水乙醇,加热回流溶解,稍冷,加入2g活性炭,继续回流20min,趁热过滤,滤液置于10℃左右析晶4h,抽滤,40ml无水乙醇洗,得白色粉末,吗替麦考酚酯30.4g,收率70%。Add 350ml of absolute ethanol to the lavender oily liquid, heat to reflux to dissolve, cool slightly, add 2g of activated carbon, continue to reflux for 20min, filter while it is hot, crystallize the filtrate at about 10°C for 4h, suction filter, wash with 40ml of absolute ethanol, Obtain white powder, mycophenolate mofetil 30.4g, yield 70%.
实施例2Example 2
在氮气保护下,Ph3P(18.4g,70mmol,1.40eq)、吗啉乙醇(6.6g,50mmol,1.0eq)溶于200ml乙酸乙酯后,冷却至0℃,控制温度不超过10℃,在15-20min 内加入DIAD(15.2g,75mmol,1.50eq)的乙酸乙酯(30ml)溶液,加毕,橙色溶液继续搅拌15min。再于0~10℃下加入麦考酚酸(17.6g,55mmol,1.10eq)的乙酸乙酯(40ml)溶液,加毕,于室温下搅拌6h。将反应液倒入150ml水中,搅拌5min,分液,有机相用60ml的1N盐酸溶液萃取一次,盐酸溶液接着用30ml乙酸乙酯洗一次,用饱和碳酸氢钠溶液调pH至8,有较多白色混浊析出,依次用50ml乙酸乙酯、20ml乙酸乙酯萃取,合并有机相,无水硫酸钠干燥,过滤,浓缩,得黄色油状液体。Under the protection of nitrogen, Ph 3 P (18.4g, 70mmol, 1.40eq) and morpholine ethanol (6.6g, 50mmol, 1.0eq) were dissolved in 200ml of ethyl acetate, cooled to 0°C, and the temperature was controlled not to exceed 10°C. A solution of DIAD (15.2g, 75mmol, 1.50eq) in ethyl acetate (30ml) was added within 15-20min. After the addition was complete, the orange solution continued to stir for 15min. Then add a solution of mycophenolic acid (17.6g, 55mmol, 1.10eq) in ethyl acetate (40ml) at 0~10°C, after the addition is complete, stir at room temperature for 6h. Pour the reaction solution into 150ml of water, stir for 5min, separate the liquids, extract the organic phase once with 60ml of 1N hydrochloric acid solution, then wash the hydrochloric acid solution once with 30ml of ethyl acetate, and adjust the pH to 8 with saturated sodium bicarbonate solution. White turbidity was precipitated, extracted with 50ml ethyl acetate and 20ml ethyl acetate successively, combined the organic phases, dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a yellow oily liquid.
往黄色油状液体中加入180ml无水乙醇,加热回流溶解,稍冷,加入1g活性炭,继续回流10min,趁热过滤,滤液置于5℃左右析晶4h,抽滤,30ml无水乙醇洗,得白色粉末,吗替麦考酚酯16.2g,收率75%。Add 180ml of absolute ethanol to the yellow oily liquid, heat to reflux to dissolve, cool slightly, add 1g of activated carbon, continue to reflux for 10min, filter while it is hot, crystallize the filtrate at about 5°C for 4h, suction filter, wash with 30ml of absolute ethanol, and get White powder, mycophenolate mofetil 16.2g, yield 75%.
实施例3Example 3
在氮气保护下,Ph3P(68.2g,260mmol,1.30eq)、吗啉乙醇(26.2g,200mmol,1.0eq)溶于2-甲基四氢呋喃(500ml)后,冷却至5℃,控制温度不超过10℃,在20-30min内加入DEAD(48.8g,280mmol,1.40eq)的2-甲基四氢呋喃(80ml)溶液,加毕,橙色溶液继续搅拌15min。再于0~10℃下加入麦考酚酸(76.9g,240mmol,1.20eq)的2-甲基四氢呋喃(150ml)溶液,加毕,于室温下搅拌6h。将反应液倒入400ml水中,搅拌5min,分液,有机相用240ml的1N盐酸溶液萃取一次,盐酸溶液接着用90ml乙酸乙酯洗一次,用饱和碳酸氢钠溶液调pH至9,有较多白色混浊析出,依次用100ml 2-甲基四氢呋喃、50ml 2-甲基四氢呋喃萃取,合并有机相,无水硫酸钠干燥,过滤,浓缩,得黄色油状液体。Under nitrogen protection, Ph 3 P (68.2g, 260mmol, 1.30eq) and morpholine ethanol (26.2g, 200mmol, 1.0eq) were dissolved in 2-methyltetrahydrofuran (500ml), cooled to 5°C, and the temperature was controlled Over 10°C, a solution of DEAD (48.8g, 280mmol, 1.40eq) in 2-methyltetrahydrofuran (80ml) was added within 20-30min. After the addition was complete, the orange solution continued to stir for 15min. Then add a solution of mycophenolic acid (76.9g, 240mmol, 1.20eq) in 2-methyltetrahydrofuran (150ml) at 0~10°C, after the addition is complete, stir at room temperature for 6h. Pour the reaction solution into 400ml of water, stir for 5min, separate the liquids, extract the organic phase once with 240ml of 1N hydrochloric acid solution, wash the hydrochloric acid solution once with 90ml of ethyl acetate, adjust the pH to 9 with saturated sodium bicarbonate solution, there are more White turbidity precipitated, extracted with 100ml 2-methyltetrahydrofuran and 50ml 2-methyltetrahydrofuran successively, combined the organic phases, dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a yellow oily liquid.
往黄色油状液体中加入650ml甲醇,加热回流溶解,稍冷,加入5g活性炭,继续回流15min,趁热过滤,滤液置于0℃左右析晶3h,抽滤,80ml甲醇洗,得白色粉末,吗替麦考酚酯58.1g,收率67%。Add 650ml of methanol to the yellow oily liquid, heat to reflux to dissolve, cool slightly, add 5g of activated carbon, continue to reflux for 15min, filter while it is hot, crystallize the filtrate at about 0°C for 3h, filter with suction, wash with 80ml of methanol, and get a white powder. Mycophenolate mofetil 58.1g, yield 67%.
实施例4Example 4
在氮气保护下,Ph3P(28.9g,110mmol,1.10eq)、吗啉乙醇(13.1g,100mmol,1.0eq)溶于200ml二氯甲烷后,冷却至0℃,控制温度不超过5℃,在20-30min 内加入DIAD(28.3g,140mmol,1.4eq)的二氯甲烷(40ml)溶液,加毕,黄色溶液继续搅拌10min。再于0~5℃下加入麦考酚酸(35.2g,110mmol,1.10eq)的二氯甲烷(50ml)溶液,加毕,于室温下搅拌4h。将反应液倒入200 ml水中,搅拌5min,分液,有机相用130ml的1N盐酸溶液萃取一次,盐酸溶液接着用60ml乙酸乙酯洗一次,用饱和碳酸氢钠溶液调pH至8,有较多白色混浊析出,依次用80ml二氯甲烷、30ml二氯甲烷萃取,合并有机相,无水硫酸钠干燥,过滤,浓缩,得淡紫色油状液体。Under the protection of nitrogen, Ph 3 P (28.9g, 110mmol, 1.10eq) and morpholine ethanol (13.1g, 100mmol, 1.0eq) were dissolved in 200ml of dichloromethane, cooled to 0°C, and the temperature was controlled not to exceed 5°C. A solution of DIAD (28.3g, 140mmol, 1.4eq) in dichloromethane (40ml) was added within 20-30min. After the addition was complete, the yellow solution continued to stir for 10min. Then add a solution of mycophenolic acid (35.2g, 110mmol, 1.10eq) in dichloromethane (50ml) at 0~5°C, after the addition is complete, stir at room temperature for 4h. The reaction solution was poured into 200 ml of water, stirred for 5 min, separated, the organic phase was extracted once with 130 ml of 1N hydrochloric acid solution, the hydrochloric acid solution was then washed once with 60 ml of ethyl acetate, and the pH was adjusted to 8 with saturated sodium bicarbonate solution. A lot of white turbidity was precipitated, extracted with 80ml dichloromethane and 30ml dichloromethane successively, combined the organic phases, dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a lavender oily liquid.
往淡紫色油状液体中加入450ml异丙醇,加热回流溶解,稍冷,加入2g活性炭,继续回流5min,趁热过滤,滤液置于10℃左右析晶6h,抽滤,50ml异丙醇洗,得白色粉末,吗替麦考酚酯31.2g,收率72%。Add 450ml of isopropanol to the lavender oily liquid, heat to reflux to dissolve, cool slightly, add 2g of activated carbon, continue to reflux for 5 minutes, filter while it is hot, crystallize the filtrate at about 10°C for 6 hours, suction filter, wash with 50ml of isopropanol, Obtain white powder, mycophenolate mofetil 31.2g, yield 72%.
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。The above descriptions are only preferred embodiments of the present invention, and all equivalent changes and modifications made according to the scope of the patent application of the present invention shall fall within the scope of the present invention.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710315619.5A CN107056736A (en) | 2017-05-08 | 2017-05-08 | A kind of preparation method of mycophenolate mofetil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710315619.5A CN107056736A (en) | 2017-05-08 | 2017-05-08 | A kind of preparation method of mycophenolate mofetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107056736A true CN107056736A (en) | 2017-08-18 |
Family
ID=59597093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710315619.5A Pending CN107056736A (en) | 2017-05-08 | 2017-05-08 | A kind of preparation method of mycophenolate mofetil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107056736A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107987043A (en) * | 2018-02-27 | 2018-05-04 | 威海贯标信息科技有限公司 | A kind of mycophenolate mofetil novel crystal forms |
| CN111153879A (en) * | 2020-03-17 | 2020-05-15 | 南京昊绿生物科技有限公司 | Mycophenolic acid-13Synthesis method of CD3 |
| CN112500378A (en) * | 2020-12-14 | 2021-03-16 | 江苏九阳生物制药有限公司 | Preparation process of mycophenolate mofetil |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1520411A (en) * | 2001-06-08 | 2004-08-11 | ����˹��ҩ�﹫˾ | The preparation method of mycophenolate mofetil |
-
2017
- 2017-05-08 CN CN201710315619.5A patent/CN107056736A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1520411A (en) * | 2001-06-08 | 2004-08-11 | ����˹��ҩ�﹫˾ | The preparation method of mycophenolate mofetil |
Non-Patent Citations (1)
| Title |
|---|
| AARON T. WRIGHT, ET AL: "The Discriminatory Power of Differential Receptor Arrays Is Improved by Prescreening—A Demonstration in the Analysis of Tachykinins and Similar Peptides", 《ANGEW. CHEM. INT. ED.》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107987043A (en) * | 2018-02-27 | 2018-05-04 | 威海贯标信息科技有限公司 | A kind of mycophenolate mofetil novel crystal forms |
| CN111153879A (en) * | 2020-03-17 | 2020-05-15 | 南京昊绿生物科技有限公司 | Mycophenolic acid-13Synthesis method of CD3 |
| CN111153879B (en) * | 2020-03-17 | 2022-09-27 | 南京昊绿生物科技有限公司 | Mycophenolic acid- 13 Synthesis method of CD3 |
| CN112500378A (en) * | 2020-12-14 | 2021-03-16 | 江苏九阳生物制药有限公司 | Preparation process of mycophenolate mofetil |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106146379B (en) | A kind of synthetic method of Oxiracetam | |
| RU2014139702A (en) | METHOD FOR PRODUCING TRIGLYCERIDES OF MEDIUM-RADIATE FATTY ACIDS | |
| JP2016538331A (en) | Synthesis of 1-alkyl-2-amino-imidazole-5-carboxylic acid esters via Cα-substituted N-alkyl-glycine ester derivatives | |
| CN107311875A (en) | The synthetic method of aramine | |
| CN107056736A (en) | A kind of preparation method of mycophenolate mofetil | |
| CN101585770B (en) | Caffeic acid diester compounds and preparation method thereof, and application thereof in preparing medicine for curing thrombus | |
| CN109503585B (en) | A kind of refining method of pentoxifylline recovered product | |
| CN102317256B (en) | Process for preparing racecadotril | |
| JPS58146560A (en) | Salicyl derivative of n-acetylcystein, manufacture and drug | |
| CN104231033A (en) | Preparation method of dutasteride | |
| CN105837658B (en) | A kind of synthetic method of argatroban | |
| CN103804234B (en) | The synthetic method of Alpha-Methyl-(3,4-Dimethoxyphenyl)-alpha-amino group propionitrile | |
| CN100395253C (en) | A method for preparing secoisolaricresinol diglucoside from flaxseed | |
| CN102180864B (en) | Preparation method of strontium ranelate | |
| CN105481809B (en) | A kind of isolation and purification method of tanshin polyphenolic acid B and the preparation method of B magnesium tanphenolate | |
| CN100478327C (en) | L-dopa methyl ester hydrochloride preparation method | |
| CN111481546B (en) | The application of alkaloids or their salts in anti-coronavirus | |
| CN108373411A (en) | The preparation method of high-purity 4- chloro-3-hydroxyl ethyl butyrates | |
| JP2019509293A (en) | 4-Pentafluorothiophenol compounds and preparation method, and preparation method of pentafluorosulfur-substituted benzopyran compounds | |
| CN100391931C (en) | Method for directly synthesizing propyl gallate from tara powder | |
| CN113651724B (en) | A method for preparing a 5-ALA conjugate and its use | |
| CN103613584B (en) | The method of a kind of Isrodipine synthetic product aftertreatment | |
| CN104434928A (en) | Application of Cleistanone O-(piperazinyl)ethyl derivative in preparation of hepatic fibrosis resisting drugs | |
| CN106854201B (en) | Purification method of rosuvastatin calcium intermediate | |
| JPS6015616B2 (en) | Method for producing N-2-(pyrrolidinylmethyl)-substituted benzamide derivative or salts thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170818 |
|
| RJ01 | Rejection of invention patent application after publication |